Mark Scimone

Dr. Mark Scimone

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EBEyal Bar-Kochba
Eyal Bar-Kochba
MSMark Scimone
Mark Scimone
JEJonathan B. Estrada
Jonathan B. Estrada
CFChristian Franck
Christian Franck
In the United States over 1.7 million cases of traumatic brain injury are reported yearly, but predictive correlation of cellular injury to impact tissue strain is still lacking, particularly for neuronal injury resulting from compression. Given the prevalence of compressive deformations in most blunt head trauma, this information is critically important for the development of future mitigation and diagnosis strategies. Using a 3D in vitro neuronal compression model, we investigated the role of impact strain and strain rate on neuronal lifetime, viability, and pathomorphology. We find that strain magnitude and rate have profound, yet distinctively different effects on the injury pathology. While strain magnitude affects the time of neuronal death, strain rate influences the pathomorphology and extent of population injury. Cellular injury is not initiated through localized deformation of the cytoskeleton but rather driven by excess strain on the entire cell. Furthermore we find that, mechanoporation, one of the key pathological trigger mechanisms in stretch and shear neuronal injuries, was not observed under compression.

1 January 2021 in Brain Multiphysics
Verified
Journal Article
Open access
JEJonathan B. Estrada
Jonathan B. Estrada
HCHarry C. Cramer
Harry C. Cramer
MSMark Scimone
Mark Scimone
SBSelda Buyukozturk
Selda Buyukozturk
CFChristian Franck
Christian Franck

11 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMark Scimone
Mark Scimone
SKSavitri Krishnamurthy
Savitri Krishnamurthy
GMGopi Maguluri
Gopi Maguluri
DPDorin Preda
Dorin Preda
JPJesung Park
Jesung Park
NINicusor Iftimia
Nicusor Iftimia
Providing surgical margin information during breast cancer surgery is crucial for the success of the procedure. The margin is defined as the distance from the tumor to the cut surface of the resection specimen. The consensus among surgeons and radiation oncologists is that there should be no tumor left within 1 to maximum 2 mm from the surface of the surgical specimen. If a positive margin remains, there is substantial risk for tumor recurrence, which may also result in potentially reduced cosmesis and eventual need for mastectomy. In this paper we report a novel multimodal optical imaging instrument based on combined high-resolution confocal microscopy-optical coherence tomography imaging for assessing the presence of potential positive margins on surgical specimens. Since rapid specimen analysis is critical during surgery, this instrument also includes a fluorescence imaging channel to enable rapid identification of the areas of the specimen that have potential positive margins. This is possible by specimen incubation with a cancer specific agent prior to imaging. In this study we used a quenched contrast agent, which is activated by cancer specific enzymes, such as urokinase plasminogen activators (uPA). Using this agent or a similar one, one may limit the use of high-resolution optical imaging to only fluorescence-highlighted areas for visualizing tissue morphology at the sub-cellular scale and confirming or ruling out cancer presence. Preliminary evaluation of this technology was performed on 20 surgical specimens and testing of the optical imaging findings was performed against histopathology. The combination of the three imaging modes allowed for high correlation between optical image analysis and histological ground-truth. The initial results are encouraging, showing instrument capability to assess margins on clinical specimens with a positive predictive value of 1.0 and a negative predictive value of 0.83.

19 November 2018 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
MSMark Scimone
Mark Scimone
HIHarry C. Cramer Iii
Harry C. Cramer Iii
EBEyal Bar-Kochba
Eyal Bar-Kochba
RARodolfo Amezcua
Rodolfo Amezcua
JEJonathan B. Estrada
Jonathan B. Estrada
CFChristian Franck
Christian Franck

1 April 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMark Scimone
Mark Scimone
HCHarry C. Cramer
Harry C. Cramer
PHPaul Hopkins
Paul Hopkins
JEJonathan B. Estrada
Jonathan B. Estrada
CFChristian Franck
Christian Franck
Therapeutic hypothermia (TH) is an attractive target for mild traumatic brain injury (mTBI) treatment, yet significant gaps in our mechanistic understanding of TH, especially at the cellular level, remain and need to be addressed for significant forward progress to be made. Using a recently-established 3D in-vitro neural hydrogel model for mTBI we investigated the efficacy of TH after compressive impact injury and established critical treatment parameters including target cooling temperature, and time windows for application and maintenance of TH. Across four temperatures evaluated (31.5, 33, 35, and 37°C), 33°C was found to be most neuroprotective after 24 and 48 hours post-injury. Assessment of TH administration onset time and duration showed that TH should be administered within 4 hours post-injury and be maintained for at least 6 hours for achieving maximum viability. Cellular imaging showed TH reduced the percentage of cells positive for caspases 3/7 and increased the expression of calpastatin, an endogenous neuroprotectant. These findings provide significant new insight into the biological parameter space that renders TH effective in mitigating the deleterious effects of cellular mTBI and provides a quantitative foundation for the future development of animal and preclinical treatment protocols.

12 November 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
TYTiffany Yu
Tiffany Yu
SDSteve J. Davis
Steve J. Davis
MSMark Scimone
Mark Scimone
JGJohn Grimble
John Grimble
GMGopi Maguluri
Gopi Maguluri
YZYoubo Zhao
Youbo Zhao
This paper presents a technique for high sensitivity measurement of singlet oxygen luminescence generated during photodynamic therapy (PDT) and ultraviolet (UV) irradiation on skin. The high measurement sensitivity is achieved by using a computational spectroscopy (CS) approach that provides improved photon detection efficiency compared to spectral filtering methodology. A solid-state InGaAs photodiode is used as the CS detector, which significantly reduces system cost and improves robustness compared to photomultiplier tubes. The spectral resolution enables high-accuracy determination and subtraction of photosensitizer fluorescence baseline without the need for time-gating. This allows for high sensitivity detection of singlet oxygen luminescence emission generated by continuous wave light sources, such as solar simulator sources and those commonly used in PDT clinics. The value of the technology is demonstrated during in vivo and ex vivo experiments that show the correlation of measured singlet oxygen with PDT treatment efficacy and the illumination intensity on the skin. These results demonstrate the potential use of the technology as a dosimeter to guide PDT treatment and as an analytical tool supporting the development of improved sunscreen products for skin cancer prevention.